Crossmark

MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6)

Published Online: 2024-02-19

Published Print: 2024-12

Authors

Ghorbani Alvanegh, Akbar

Arpanaei, Ayyoob

Esmaeili Gouvarchin Ghaleh, Hadi

Mohammad Ganji, Shahla
Funding

Funding for this research was provided by:

Iran National Science Foundation (4004225)
License Information

Text and Data Mining valid from 2024-02-19

Version of Record valid from 2024-02-19
More Information

Article History

Received: 5 October 2023

Accepted: 2 January 2024

First Online: 19 February 2024

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

Document is current